The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19

被引：0

作者：

Azimi, Saeid ^{[1
]}

Saghafi, Fatemeh ^{[2
]}

Mohammadi, Mohammad Hossein ^{[3
]}

Moghimi, Mohammad Hossein ^{[4
]}

Akhavan, Seyed Ali ^{[4
]}

Khataminia, Masoud ^{[5
]}

Shirvani, Maria ^{[6
]}

Sohrevardi, Seyed Mojtaba ^{[2
]}

Jamialahmadi, Tannaz ^{[7
]}

Sahebnasagh, Adeleh ^{[8
]}

Sahebkar, Amirhossein ^{[7
,9
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Student Res Comm, Fac Pharm, Tehran, Iran

[2] Shahid Sadoughi Univ Med Sci, Fac Pharm & Pharmaceut Sci, Res Ctr, Dept Clin Pharm, Yazd, Iran

[3] Shahid Sadoughi Univ Med Sci, Yazd, Iran

[4] Shahid Sadoughi Univ Med Sci, Student Res Comm, Fac Pharm, Yazd, Iran

[5] Univ Tehran Med Sci, Student Res Comm, Fac Pharm, Tehran, Iran

[6] Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Kermanshah, Iran

[7] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran

[8] North Khorasan Univ Med Sci, Dept Internal Med, Clin Res Ctr, Bojnurd, Iran

[9] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran

来源：

CURRENT PHARMACEUTICAL DESIGN | 2023年 / 29卷 / 29期

关键词：

COVID-19; acute respiratory distress syndrome; cytokine; survival rate; immunosuppressant; cannabidiol; DOMAIN-LIKE RECEPTORS; CBD; PATHOGENESIS; INFLAMMATION; SYMPTOMS;

D O I：

10.2174/0113816128275803230920094909

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

COVID-19 disease manifests itself in a wide range of signs and symptoms, beginning with mild symptoms, such as fever, cough, and dyspnea, progressing to acute respiratory distress syndrome (ARDS) and death in some cases. The cytokine storm, or an excess of cytokines released locally, is assumed to be the primary cause of ARDS and mortality in COVID-19 patients. To enhance the survival rate of COVID-19 patients, early management of the cytokine storm with immunomodulators is crucial. Although the effectiveness of some immunosuppressants, such as corticosteroids and tocilizumab, has been studied in clinical trials, the administration of these drugs should be exercised cautiously. Cannabidiol (CBD) is a non-psychotropic phytocannabinoid from Cannabis sativa extracts with anti-inflammatory properties. This review is intended to discuss the possible utility of CBD for the management of COVID-19 patients, particularly those with ARDS.

引用

页码：2291 / 2296

页数：6

共 50 条

[1] Acute respiratory distress syndrome in COVID-19
Dadashzadeh, Nahid
Farshid, Saman
Valizadeh, Rohollah
Nanbakhsh, Mohammad
Rahimi, Mohsen Mohammad
[J]. IMMUNOPATHOLOGIA PERSA, 2020, 6 (02):
[2] Understanding COVID-19 Acute Respiratory Distress Syndrome
Singh, Anchit Raj
Kumar, Raj
Sinha, Anwita
[J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (01) : 150 - 150
[3] Management of Acute Respiratory Distress Syndrome in COVID-19 Patients
Segers, J.
Hadzic, A.
Van Boxstael, S.
Van Herreweghe, I
De Fre, O.
[J]. ACTA ANAESTHESIOLOGICA BELGICA, 2022, 73 (01) : 5 - 14
[4] Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not?
Maley, Jason H.
Winkler, Tilo
Hardin, C. Corey
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (04) : 618 - 619
[5] Biological Mechanisms of COVID-19 Acute Respiratory Distress Syndrome
Matthay, Michael A.
Leligdowicz, Aleksandra
Liu, Kathleen D.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (11) : 1489 - 1491
[6] Acute Respiratory Distress Syndrome During the COVID-19 Era
White, Cole J.
White, Bailey Slone
Wadhwa, Sanju R.
Aouad, Arlette
[J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (02) : 1 - 3
[7] Pneumothorax and pneumomediastinum in COVID-19 acute respiratory distress syndrome
Lal, Amos
Mishra, Ajay Kumar
Akhtar, Jamal
Nabzdyk, Christoph
[J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2021, 91 (02)
[8] Pneumomediastinum in Acute Respiratory Distress Syndrome from COVID-19
Mart, Matthew F.
Norfolk, Stephanie G.
Flemmons, Lisa N.
Stokes, John W.
Bacchetta, Matthew D.
Trindade, Anil J.
Casey, Jonathan D.
Semler, Matthew W.
Ely, E. Wesley
Noto, Michael J.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (02) : 237 - 238
[9] Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome
Matthay, Michael A.
Wick, Katherine D.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (12): : 6218 - 6221
[10] Inhaled NO in COVID-19 Acute Respiratory Distress Syndrome: Yes or No?
Lal, Amos
Gladwin, Mark T.
Gajic, Ognjen
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (12) : 1259 - 1261

← 1 2 3 4 5 →